Virpax & HHS Partner on NES100 for Pain Relief
Virpax Pharmaceuticals has announced an extension of its research agreement with the National Center for Advancing Translational Sciences (NCATS),...
Virpax Pharmaceuticals has announced an extension of its research agreement with the National Center for Advancing Translational Sciences (NCATS),...
Synedgen, Inc., a biotechnology company specializing in gastrointestinal disease treatment, has secured a $2.2 million contract from the Joint...
Precision BioSciences, a clinical-stage gene editing company, has announced a significant advancement in its quest to cure chronic hepatitis...
Medable, a leading clinical trial technology platform, has been recognized as a Trailblazer in Everest Group’s first-ever “Clinical Trial...
Terray Therapeutics, a biotechnology company revolutionizing small molecule drug development, has secured $120 million in Series B funding. This...
Clinical laboratories face a critical deadline: achieving Phase One compliance with the FDA’s Laboratory Developed Test (LDT) rule by...
Charles River Laboratories International, Inc. has introduced the Retrogenix® Non-Human Protein Library, a tool designed to assist biopharmaceutical companies...
Shionogi & Co., Ltd. has released new data from PROVE, a large-scale global study examining real-world evidence for Fetroja®/Fetcroja®...
TheraVectys, a biotechnology company specializing in lentiviral vector-based vaccines and immunotherapies, has begun enrolling patients in a Phase I/IIa...
The Paris Commercial Court has granted an extension of receivership proceedings for ACTICOR Biotech, a biopharmaceutical company focused on...